1/ Our review of time toxicity in lymphoma & multiple myeloma, led by my @fredhutch neighbor @DiMengyang, now out in Leukemia & Lymphoma!
As treatments get better in #lymsm & #MMsm, important to consider time at home in protocols & SOC workflows.
tandfonline.com/eprint/HXAE8…
Another great meeting of the UK Myeloma Research Alliance (UKMRA) today!
Really pleased to see our growing group of researchers developing innovative clinical trials. @UKMyelomaSoc
#ASCT stills a good option in patients with multiple myeloma, this confort in countries with lack access (as mine) to new therapies, excellent talk by @profBigG#EBMT@TheEBMT
📣📣Come and join us at the myeloma educational session this afternoon at EMBT!
Lots to discuss from transplants, CAR-T and equity of access. #EBMT24@profBigG@_DrCP
Thrilled to share that our BRC members, Professor Hemant Pandit & Professor Gordon Cook, have earned esteemed roles as NIHR Senior Investigators! Congratulations on this impressive achievement!
shorturl.at/uGPW4@NIHRresearch@HPandit_ortho@profBigG